Restoring the America Invents Act
Legislative Progress
Introduced
September 29, 2021
Latest Action
September 29, 2021
Primary Sponsor
Patrick J. LeahyDemocratic(VT)
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 5,357 other S bills in the 117th — cohort avg 38d
Restoring the America Invents Act This bill modifies various provisions related to administrative patent validity review proceedings conducted before the Patent Trial and Appeal Board (PTAB), a body within the Patent and Trademark Office (PTO). For example, the bill expands the scope of inter partes reviews (IPRs), one type of such review proceedings, by allowing challenges to a patent's validity based on statutory or obviousness-type double patenting grounds; authorizes the PTO director to review, modify, or set aside final PTAB decisions; authorizes governmental entities to file IPRs and post-grant reviews (PGRs), a related type of patent review proceeding; requires the PTO to institute an IPR (i.e., a decision to proceed with the full IPR proceeding) if there's a reasonable likelihood that the petitioner will prevail, subject to limited exceptions; establishes in statute factors for a court to consider when deciding a request to stay a patent infringement lawsuit involving a patent subject to a pending IPR or PGR; modifies provisions related to the joinder of parties and handling of multiple proceedings involving the same patent before the PTO; and modifies provisions relating to the time limitation for filing an IPR, including by establishing that a lawsuit dismissed without prejudice does not trigger the time limitation (generally, a petitioner wishing to file an IPR must do so within one year of being served a lawsuit alleging infringement of the patent).
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (49)
Read twice and referred to the Committee on the Judiciary. (Sponsor introductory remarks on measure: CR S6782-6783)
Introduced in Senate
Bills with similar content found using semantic analysis.
Sources: Congress.gov
2026 · third_quarter · Copyright/Patent/Trademark
H.R. 170 SMART Act Draft PARTS Act S. 2891 Restoring America Invents Act HR 5184 Advancing Americas Interests Act
Client expense: $1,711,820 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · second_quarter · Copyright/Patent/Trademark
H.R. 170 SMART Act Draft PARTS Act S. 2891 Restoring America Invents Act HR 5184 Advancing Americas Interests Act
Client expense: $1,930,500 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · first_quarter · Copyright/Patent/Trademark
H.R. 170 SMART Act Draft PARTS Act S. 2891 Restoring America Invents Act HR 5184 Advancing Americas Interests Act
Client expense: $1,244,015 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · first_quarter · Copyright/Patent/Trademark
H.R. 170 SMART Act Draft PARTS Act S. 2891 Restoring America Invents Act HR 5184 Advancing Americas Interests Act
Client expense: $1,244,015 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · fourth_quarter · Copyright/Patent/Trademark
H.R. 170 SMART Act Draft PARTS Act S. 2891 Restoring America Invents Act HR 5184 Advancing Americas Interests Act
Client expense: $1,553,187 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
| Republican |
| ID |
| Richard Blumenthal | Democratic | CT |
2025 · third_quarter · Copyright/Patent/Trademark
H.R. 170 SMART Act Draft PARTS Act S. 2891 Restoring America Invents Act HR 5184 Advancing Americas Interests Act
Client expense: $1,618,086 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · second_quarter · Copyright/Patent/Trademark
H.R. 170 SMART Act Draft PARTS Act S. 2891 Restoring America Invents Act HR 5184 Advancing Americas Interests Act
Client expense: $1,943,852 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · first_quarter · Copyright/Patent/Trademark
H.R. 170 SMART Act Draft PARTS Act S. 2891 Restoring America Invents Act HR 5184 Advancing Americas Interests Act
Client expense: $1,235,360 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · fourth_quarter · Copyright/Patent/Trademark
H.R. 170 SMART Act Draft PARTS Act S. 2891 Restoring America Invents Act HR 5184 Advancing Americas Interests Act
Client expense: $1,225,684 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · third_quarter · Copyright/Patent/Trademark
H.R. 170 SMART Act Draft PARTS Act S. 2891 Restoring America Invents Act HR 5184 Advancing Americas Interests Act
Client expense: $1,521,648 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · second_quarter · Copyright/Patent/Trademark
H.R. 170 SMART Act Draft PARTS Act S. 2891 Restoring America Invents Act HR 5184 Advancing Americas Interests Act
Client expense: $1,911,970 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · first_quarter · Copyright/Patent/Trademark
H.R. 170 SMART Act Draft PARTS Act S. 2891 Restoring America Invents Act HR 5184 Advancing Americas Interests Act
Client expense: $1,288,650 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · fourth_quarter · Copyright/Patent/Trademark
H.R. 170 SMART Act Draft PARTS Act S. 2891 Restoring America Invents Act HR 5184 Advancing Americas Interests Act
Client expense: $1,430,505 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · first_quarter · Copyright/Patent/Trademark
Patent quality issues - S.2891, Restoring the America Invents Act
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Copyright/Patent/Trademark
Software copyright and related policy issues. Software patents and related policy issues. S. 2891, Restoring the America Invents Act. S. 4417, Patent Trial and Appeal Board Reform Act of 2022. S. 2774, Pride in the Patent Ownership Act. S. 2773, Unleashing American Innovators Act. Copyright Office modernization. H.R. 5374, SHOP SAFE Act. S. 3880, Strengthening Measures to Advance Rights Technologies (SMART) Copyright Act of 2022. S. 4734, Patent Eligibility Restoration Act of 2022.
Client expense: $2,540,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Patent & Trademark Office (PTO), SENATE, Treasury, Dept of, U.S. Copyright Office, U.S. Trade Representative (USTR)
2022 · fourth_quarter · Copyright/Patent/Trademark
S.1435 Affordable Prescriptions for Patients Act H.R.2873 Affordable Prescriptions for Patients Through Promoting Competition Act H.R. 2884 Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act S 2891 Restore the America Invents Act S. 2774 - Pride in Patent Ownership Act S. 4704 - Patent Examination and Quality Improvement Act of 2022 S. 4417 - Patent Trial and Appeal Board Reform Act of 2022 S. 4430 - Interagency Patent Coordination and Improvement Act of 2022 FTC related issues Issues related to the Patent Act Issues related to march-in/Bayh Dole, WTO/TRIPS waiver, no specific bill
Client expense: $2,140,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Copyright/Patent/Trademark
Software copyright and related policy issues. Software patents and related policy issues. S. 2891, Restoring the America Invents Act. S. 4417, Patent Trial and Appeal Board Reform Act of 2022. S. 2774, Pride in the Patent Ownership Act. S. 2773, Unleashing American Innovators Act. Copyright Office modernization. H.R. 5374, SHOP SAFE Act. S. 3880, Strengthening Measures to Advance Rights Technologies (SMART) Copyright Act of 2022. S. 4734, Patent Eligibility Restoration Act of 2022.
Client expense: $2,540,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Patent & Trademark Office (PTO), SENATE, Treasury, Dept of, U.S. Copyright Office, U.S. Trade Representative (USTR)
2022 · third_quarter · Copyright/Patent/Trademark
Software copyright and related policy issues. Software patents and related policy issues. S. 2891, Restoring the America Invents Act. S. 4417, Patent Trial and Appeal Board Reform Act of 2022. S. 2774, Pride in the Patent Ownership Act. S. 2773, Unleashing American Innovators Act. Copyright Office modernization. H.R. 5374, SHOP SAFE Act. S. 3880, Strengthening Measures to Advance Rights Technologies (SMART) Copyright Act of 2022. S. 4734, Patent Eligibility Restoration Act of 2022.
Client expense: $2,300,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Patent & Trademark Office (PTO), SENATE, Treasury, Dept of, U.S. Copyright Office, U.S. Trade Representative (USTR)
2022 · second_quarter · Copyright/Patent/Trademark
Software copyright and related policy issues. Software patents and related policy issues. S. 2891, Restoring the America Invents Act. S. 4417, Patent Trial and Appeal Board Reform Act of 2022. S. 2774, Pride in the Patent Ownership Act. S. 2773, Unleashing American Innovators Act. Subject matter eligibility under patent law. Copyright Office modernization. H.R. 5374, SHOP SAFE Act. S. 3880, Strengthening Measures to Advance Rights Technologies (SMART) Copyright Act of 2022.
Client expense: $2,410,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Patent & Trademark Office (PTO), SENATE, Treasury, Dept of, U.S. Copyright Office, U.S. Trade Representative (USTR)
2022 · second_quarter · Copyright/Patent/Trademark
General lobbying with respect to patent demand letters. S. 2891, Restoring the America Invents Act. Draft legislation to increase franchisee rights. Draft legislation regarding inventor rights. Draft legislation on name and likeness rights for NCAA athletes.
Client expense: $1,010,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Copyright/Patent/Trademark
I have discussed patent eligibility issues and potential amendments to 35 USC 101, including S.4734 (the Patent Eligibility Restoration Act of 2022). I have also discussed potential amendments to the inter partes review process (35 USC 311 et seq), including those proposed in previous Congresses, e.g., S.2082 and H.R.3666 (STRONGER Patents Act of 2019). I have also addressed some of the provisions relating to patent litigation contained in these two bills (such as the abrogation of the holding in eBay v. MercExchange). I have discussed discretionary denials of institution by the Patent Trial and Appeals Board (PTAB) and potential remedies for the potential Appointments Clause problem for the PTAB, which are addressed in S.2891 (Restoring the America Invents Act). I have also discussed general patent quality issues and the funding of the U.S. Patent and Trademark through fees, which do not relate directly (for now) to any particular bill. I have also discussed the mandatory recordation of patent assignments as addressed in S.2774 (Pride in Patent Ownership Act). Finally, I have discussed efforts to expand innovation and patenting to be more inclusive of persons with diverse backgrounds, including two bills that would authorize the Patent and Trademark Office to collect certain voluntarily-submitted demographic information: e.g., H.R.1723 and S.632 (the IDEA Act) and one that would take a variety of other actions to expand American innovation: S.2773 (Unleashing American Innovators Act of 2021). Additionally, I have advocated against H.R.5874 - the Restoring Americas Leadership in Innovation Act of 2021 and in favor of S.4417 - the Patent Trial and Appeal Board Reform Act of 2022.
Client expense: Not reported · Firm income: $99,000
Government targets: Commerce, Dept of (DOC), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Patent & Trademark Office (PTO), SENATE, White House Office
2022 · fourth_quarter · Copyright/Patent/Trademark
Monitor issues related to patent policy, including Advancing America's Interest Act, H.R. 5184, Restoring the America Invents Act, S. 2891, and the Patent Trial and Appeals Board Reform Act (S.4417).
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Copyright/Patent/Trademark
Issues related to Inter Partes Review and patent policy generally; Preserving Access to Affordable Generics and Biosimilars Act, S. 1428, H.R. 2891; Affordable Prescriptions for Patients Act, S.1435, H.R. 2873; Restoring the America Invents Act, S. 2891.
Client expense: Not reported · Firm income: $70,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Copyright/Patent/Trademark
Issues related to patent policy and reform, including Restoring the America Invents Act, S. 2891 and the Patent Trial and Appeal Board Reform Act of 2022, S.4417.
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
2022 · fourth_quarter · Copyright/Patent/Trademark
Issues related to intellectual property legislation and regulation; S. 2891, Restoring the America Invents Act; S. 4704, Patent Examination and Quality Improvement Act of 2022; S. 2773, Unleashing American Innovators Act; S. 2774, Pride in Patent Ownership Act
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE
2022 · fourth_quarter · Copyright/Patent/Trademark
Intellectual property and patent issues; S. 2891, Restoring the America Invents Act; S. 4704, Patent Examination and Quality Improvement Act of 2022
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Copyright/Patent/Trademark
Issues related to intellectual property protections and enforcement in S.2891, Restoring the America Invents Act and S.2067, SECRETS Act of 2021
Client expense: $990,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), Natl Security Council (NSC), SENATE
2022 · fourth_quarter · Copyright/Patent/Trademark
Patent quality issues - S.2891, Restoring the America Invents Act
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Copyright/Patent/Trademark
Patents in general Design patents in general PTAB in general S. 2891 Restoring the America Invents Act S. 3772, Defending American Courts Act S. 4734, Patent Eligibility Restoration Act S 936, INFORM Consumers Act HR 5502, INFORM Consumers Act HR 7776, National Defense Authorization Act for Fiscal Year 2023, INFORM Consumers Act HR 2617, Consolidated Appropriations Act, 2023, Vehicle Repair and INFORM Consumers Act
Client expense: $477,409 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Copyright/Patent/Trademark
H.R. 2891, Preserve Access to Affordable Generics and Biosimilars Act H.R. 2873, Affordable Prescriptions for Patients Through Promoting Competition Act of 2021 H.R. 2883, Stop Stalling Access to Affordable Medications H.R. 2884, Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act S. 2774, Pride in Patent Ownership Act S. 2891, Restoring the America Invents Act Patent litigation reform issues and issues related to post-grant proceedings at the USPTO Value of intellectual property
Client expense: $970,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Copyright/Patent/Trademark
Software copyright and related policy issues. Software patents and related policy issues. S. 2891, Restoring the America Invents Act. S. 4417, Patent Trial and Appeal Board Reform Act of 2022. S. 2774, Pride in the Patent Ownership Act. S. 2773, Unleashing American Innovators Act. Copyright Office modernization. H.R. 5374, SHOP SAFE Act. S. 3880, Strengthening Measures to Advance Rights Technologies (SMART) Copyright Act of 2022. S. 4734, Patent Eligibility Restoration Act of 2022.
Client expense: $2,540,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Patent & Trademark Office (PTO), SENATE, Treasury, Dept of, U.S. Copyright Office, U.S. Trade Representative (USTR)
2022 · fourth_quarter · Copyright/Patent/Trademark
Patent Settlements. Patent Abuse. Skinny Labeling. Inter Partes Review. Impact of IPR decisions on 30-month stay. IPR Amendments. Enhancing Quality of Patents through the PTAB. S.2891: Restoring the America Invents Act. S.4417: Patent Trial and Appeal Board Reform Act of 2022. S.4430: Interagency Patent Coordination and Improvement Act of 2022. S.4704: Patent Examination and Quality Improvement Act of 2022. H.R.6381/S.3521: CREATE Act of 2022.
Client expense: $900,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), SENATE
2022 · fourth_quarter · Copyright/Patent/Trademark
H.R. 1629: Fairness in Orphan Drug Exclusivity Act - Provisions related to FDA policy and orphan drugs H.R. 2148: Prescription Drug Price Relief Act of 2021 - Provisions related to prescription drug pricing and march-in rights H.R. 2873: Affordable Prescriptions for Patients Through Promoting Competition Act of 2021 - Provisions related to intellectual property and patents H.R. 2884: Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act - Provisions related to patent infringement H.R. 2891: Preserve Access to Affordable Generics and Biosimilars Act - Provisions related to patent settlements H.R. 5635: Intellectual Property Violators Accountability and Transparency Act - Provisions related to intellectual property protections H.R. 5874: Restoring Americas Leadership in Innovation Act of 2021 - Provisions related to intellectual property protections S. 250: Fairness in Orphan Drug Exclusivity Act - Provisions related to FDA policy and orphan drugs S. 415: A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to the scope of new chemical exclusivity (Public Law 117-9) - Provisions related to FDA policy and exclusivity S. 1428: Preserve Access to Affordable Generics and Biosimilars Act - Provisions related to patent settlements S. 1435: Affordable Prescriptions for Patients Act of 2021 - Provisions related to intellectual property and patents S. 2773: Unleashing American Innovators Act or 2021 - Provisions related to USPTO policy S. 2774: Pride in Patent Ownership Act - Provisions related to patent transparency S. 2891: Restoring the America Invents Act - A bill to amend title 35, United States Code, to address matters relating to the Patent Trial and Appeal Board of the United States Patent and Trademark Office, and for other purposes S. 2910: Expanding Access to Low-Cost Generics Act of 2021 - To amend the Federal Food, Drug, and Cosmetic Act with respect to the 180-day exclusivity period, and for other purposes S. 4417: Patent Trial and Appeal Board Reform Act of 2022 - To amend title 35, United States Code, to address matter relating to the Patent Trial and Appeal Board of the United States Patent and Trademark Office, and for other purposes S. 4430: Interagency Patent Coordination and Improvement Act of 2022 S. 4704: Patent Examination and Quality Improvement Act of 2022 S. 4918: Increasing Prescription Drug Competition Act - Patent-related policy issues Biopharmaceutical innovation and patent policy issues Bayh-Dole march-in rights policy issues
Client expense: $860,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE
2022 · fourth_quarter · Copyright/Patent/Trademark
H.R. 1629: Fairness in Orphan Drug Exclusivity Act - Provisions related to FDA policy and orphan drugs H.R. 2148: Prescription Drug Price Relief Act of 2021 - Provisions related to prescription drug pricing and march-in rights H.R. 2873: Affordable Prescriptions for Patients Through Promoting Competition Act of 2021 - Provisions related to intellectual property and patents H.R. 2884: Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act - Provisions related to patent infringement H.R. 2891: Preserve Access to Affordable Generics and Biosimilars Act - Provisions related to patent settlements H.R. 5635: Intellectual Property Violators Accountability and Transparency Act - Provisions related to intellectual property protections H.R. 5874: Restoring Americas Leadership in Innovation Act of 2021 - Provisions related to intellectual property protections S. 250: Fairness in Orphan Drug Exclusivity Act - Provisions related to FDA policy and orphan drugs S. 415: A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to the scope of new chemical exclusivity (Public Law 117-9) - Provisions related to FDA policy and exclusivity S. 1428: Preserve Access to Affordable Generics and Biosimilars Act - Provisions related to patent settlements S. 1435: Affordable Prescriptions for Patients Act of 2021 - Provisions related to intellectual property and patents S. 2773: Unleashing American Innovators Act of 2021 - Provisions related to USPTO policy S. 2774: Pride in Patent Ownership Act - Provisions related to patent transparency S. 2891: Restoring the America Invents Act - A bill to amend title 35, United States Code, to address matters relating to the Patent Trial and Appeal Board of the United States Patent and Trademark Office, and for other purposes S. 2910: Expanding Access to Low-Cost Generics Act of 2021 - To amend the Federal Food, Drug, and Cosmetic Act with respect to the 180-day exclusivity period, and for other purposes S. 4417: Patent Trial and Appeal Board Reform Act of 2022 - To amend title 35, United States Code, to address matters relating to the Patent Trial and Appeal Board of the United States Patent and Trademark Office, and for other purposes S. 4430: Interagency Patent Coordination and Improvement Act of 2022 S. 4704: Patent Examination and Quality Improvement Act of 2022 S. 4918: Increasing Prescription Drug Competition Act - Patent-related policy issues Biopharmaceutical innovation and patent policy issues Bayh-Dole march-in rights policy issues
Client expense: $6,610,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE
2022 · fourth_quarter · Copyright/Patent/Trademark
S. 2891, Restoring the America Invents Act; S. 2774, Pride in the Patent Ownership Act; S. 2773, Unleashing American Innovators Act. H.R. 5374, SHOP SAFE Act; S.3880, SMART Copyright Act of 2022; S.4417 Patent Trial and Appeal Board Reform Act of 2022; S. 4734, Patent Eligibility Restoration Act of 2022 Software copyright and related policy issues. Software patents and related policy issues. Subject matter eligibility under patent law. Matters related to the US Copyright Office. Review of the Digital Millenium Copyright Act. Administrative review proceedings under the America Invents Act. Copyright office modernization.
Client expense: $1,330,000 · Firm income: Not reported
Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), Patent & Trademark Office (PTO), SENATE, U.S. Copyright Office, U.S. Trade Representative (USTR)
2022 · fourth_quarter · Copyright/Patent/Trademark
Issues relating to legislation regarding patents; S. 2891, the Restoring the America Invents Act; S. 4417, Patent Trial and Appeal Board Reform Act of 2022; S. 2774, the Pride in Patent Ownership Act; S. 4704, the Patent Examination and Quality Improvement Act; S. 4734, the Patent Eligibility Restoration Act of 2022; H.R. 7900, S. 4543, the National Defense Authorization Act for Fiscal Year 2023.
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Copyright/Patent/Trademark
Copyright and Patent Reform, Copyright enforcement, Copyright modernization, Intermediary liability, Section 301, IPR, RAIA S2891
Client expense: $140,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE, U.S. Copyright Office
2022 · fourth_quarter · Copyright/Patent/Trademark
Copyright and Patent Reform, Copyright enforcement, Copyright modernization, Intermediary liability, Section 301, IPR, RAIA S2891
Client expense: $140,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE, U.S. Copyright Office
2022 · fourth_quarter · Copyright/Patent/Trademark
General lobbying with respect to patent demand letters. S. 2891, Restoring the America Invents Act. Draft legislation to increase franchisee rights. Draft legislation regarding inventor rights. Draft legislation on name and likeness rights for NCAA athletes.
Client expense: $1,170,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Copyright/Patent/Trademark
Protection of inter partes review process to invalidate improperly granted patents. S. 2891 - Restoring the America Invents Act S. 4417 - PTAB Reform Act
Client expense: Not reported · Firm income: $30,000
Government targets: SENATE
2022 · fourth_quarter · Copyright/Patent/Trademark
S.1435 Affordable Prescriptions for Patients Act H.R.2873 Affordable Prescriptions for Patients Through Promoting Competition Act H.R. 2884 Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act S 2891 Restore the America Invents Act S. 2774 - Pride in Patent Ownership Act S. 4704 - Patent Examination and Quality Improvement Act of 2022 S. 4417 - Patent Trial and Appeal Board Reform Act of 2022 S. 4430 - Interagency Patent Coordination and Improvement Act of 2022 FTC related issues Issues related to the Patent Act Issues related to march-in/Bayh Dole, WTO/TRIPS waiver, no specific bill
Client expense: $2,140,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Copyright/Patent/Trademark
HR 3429 SHOP SAFE Act S. 936 INFORM Consumers Act and house companion - H.R. 5502 HR 3664 SMART Act Draft PARTS Act S. 2891 Restoring America Invents Act HR 5184 Advancing Americas Interests Act
Client expense: $1,302,039 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Automotive Industry
HR 1304: Restore deductions for research and experimental expenditures HR 3664: SMART Act HR 3684: Infrastructure Investment and Jobs Act HR 3694: Preventing Auto Recycling Thefts (PART) Act HR 4521: America COMPETES Act of 2022 HR 5184: Advancing Americas Interests Act HR 5376: Inflation Reduction Act of 2022 HR 5502/S 936: INFORM Consumers Act HR 6394: PART Act HR 6566: Freedom to Repair Act HR 6570: REPAIR Act HR 8152: American Data Privacy and Protection Act S 1260: United States Innovation and Competition Act of 2021 S 2891: Restoring the America Invents Act Autonomous Vehicle Legislation (no bill no. at this time) CHIPS and Science Act of 2022 Critical Minerals Legislation Draft Electric Vehicle Incentive Legislation Draft Right to Repair Legislation Electric Vehicle Task Force EPGHG/CAFE National Electric Vehicle Infrastructure Program (IIJA) Reconciliation Package Right to Repair Semiconductor Supply Chain Telematics 5.9 GHz Spectrum
Client expense: $1,061,778 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Energy, Dept of, Environmental Protection Agency (EPA), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Natl Highway Traffic Safety Administration (NHTSA), SENATE, Transportation, Dept of (DOT), Treasury, Dept of, White House Office
2022 · fourth_quarter · Copyright/Patent/Trademark
Issues relating to improving patent quality and reducing unnecessary and abusive patent litigation: S.2774, Pride in Patent Ownership Act; S.2891, Restoring the America Invents Act. Issues relating to improving USPTO policies and operations to improve patent quality (no specific legislation). Issues relating to modernizing the ITC process and protecting American industries from unfair foreign competition: H.R. 5184, Advancing America's Interests Act; S.1260, United States Innovation and Competition Act of 2021; H.R. 4521, America COMPETES Act of 2022. Issues relating to addressing standard essential patents (no specific legislation). Issues relating to protecting intellectual property rights in international forums (no specific legislation). Issues relating to protecting against counterfeit goods in e-commerce: H.R. 3429 & S.1843, Stopping Harmful Offers on Platforms by Screening Against Fakes in E-Commerce (SHOP SAFE) Act.
Client expense: $1,130,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE, White House Office
2022 · fourth_quarter · Copyright/Patent/Trademark
Antitrust Legislation ---S.225: Competition and Antitrust Law Enforcement Reform Act of 2021 Bayh-Dole Act/Tech Transfer ---Bayh-Dole Act ---March-In Rights Compulsory Licensing ---H.R.2148/S.909: Prescription Drug Price Relief Act ---H.R.4811: Medicare Negotiation and Competitive Licensing Act Coronavirus (COVID-19) Pandemic ---Restrictions on Intellectual Property Rights ---TRIPS Waiver Data Privacy Issues ---H.R.8152: American Data Privacy and Protection Act ---S.2499: Setting an American Framework to Ensure Data Access, Transparency, and Accountability (SAFE DATA) Act Diversity in Patenting ---H.R.1723/S.632: Inventor Diversity for Economic Advancement (IDEA) Act of 2021 Drug Patenting ---H.R.2873: Affordable Prescriptions for Patients Through Promoting Competition Act of 2021 ---H.R.2883/S.1485: Stop Stalling Access to Affordable Medications ---H.R.2884: Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act of 2021 ---H.R.2891/S.1428: Preserve Access to Affordable Generics and Biosimilars Act ---S.1435: Affordable Prescriptions for Patients Act of 2021 ---S.2773: Unleashing American Innovators Act of 2021 ---S.2774: Pride in Patent Ownership Act ---S.2891: Restoring the America Invents Act ---S.4430: Interagency Patent Coordination and Improvement Act of 2022 ---Restrictions on Intellectual Property Rights Intellectual Property Enforcement ---TRIPS Waiver Inter Partes Review ---H.R.5874: Restoring America's Leadership in Innovation Act ---S.2774: Pride in Patent Ownership Act ---S.2891: Restoring the America Invents Act ---Implementation of the America Invents Act of 2011 ---Support Technology and Research for Our Nations Growth and Economic Resilience (STRONGER) Patents Act (Discussion Draft) Patent Reform ---S.4417: Patent Trial and Appeal Board Reform Act of 2022 ---S.4430: Interagency Patent Coordination and Improvement Act of 2022 ---Patent Litigation Reform Patenting of Biological Inventions ---35 USC Section 101 on Patent Eligibility ---Section 101 Modernization Patenting of Humanitarian Technologies ---H.R.5796: Patents for Humanity Act of 2021 United States-Mexico-Canada Agreement (USMCA) ---Mexico Draft Decree Banning Genetically Modified Corn
Client expense: $3,740,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Security Council (NSC), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), White House Office
2022 · fourth_quarter · Copyright/Patent/Trademark
Patents in general Design patents in general PTAB in general S. 2891 Restoring the America Invents Act S. 3772, Defending American Courts Act S. 4734, Patent Eligibility Restoration Act S 936, INFORM Consumers Act HR 5502, INFORM Consumers Act HR 7776, National Defense Authorization Act for Fiscal Year 2023, INFORM Consumers Act HR 2617, Consolidated Appropriations Act, 2023, Vehicle Repair and INFORM Consumers Act
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Copyright/Patent/Trademark
S. 4704, the Patent Examination and Quality Improvement Act of 2022 S. 4417, the PTAB Reform Act S. 4430, the Interagency Patent Coordination and Improvement Act of 2022. S. 3880, the SMART Copyright Act of 2022 S. 3772, the Defending American Courts Act H.R. 6769, the Pro Codes Act H.R. 6570, the REPAIR Act H.R. 5902, the CLEAR Patents Act of 2021 H.R. 5874, Restoring Americas Leadership in Innovation Act of 2021 S. 2774, Pride in Patent Ownership S. 2773, Unleashing American Innovators Act S. 2891, the Restoring the America Invents Act H.R. 5184, the Advancing Americas Interests Act H.R. 5374, the SHOP SAFE Act S, 3549, the Agricultural Right to Repair Act H.R. 4006 the Fair Repair Act H.R. 3978, To make it unlawful to send a demand letter in bad faith for a patent relating to COVID-19 related products H.R. 3429, the SHOP SAFE Act S. 1843, the SHOP SAFE Act S. 2067, the SECRETS Act S. 1924, the Protecting IP Act of 2021 S. 1294, the Protecting American Intellectual Property Act of 2021 S. 1245, CCP Trade Secrets Act S. 1159, To enhance the authority of U.S. Customs and Border Protection to share information S. 936, the INFORM Consumers Act H.R. 1367/S. 483, the Workforce Mobility Act of 2021 H.R. 1723/S. 632, IDEA Act H.R. 653, Research Advancing to Market Production for Innovators Act H.R. 192, Targeting Rogue and Opaque Letters Act H.R. 597, the Pandemic Treatment Access and Affordability Act of 2021 H.R. 153, Protecting Consumer Access to Generic Drugs Act of 2021 H.R. 704/S. 169, the ARTS Act H.R. 824, the Stop Chinas IP Theft Act S. 39, Protecting American Innovation and Development Act of 2021 Issues related to USPTO operations Issues related to international patent harmonization Issues related to patent subject matter eligibility Issues related to Copyright Office Modernization Issues related to the WTO TRIPs Waiver Request H.R. 4505, Commerce, Justice, Science, and Related Agencies Appropriations Act, 2022
Client expense: Not reported · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Library of Congress (LOC), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, U.S. Trade Representative (USTR), White House Office
2022 · fourth_quarter · Copyright/Patent/Trademark
S. 2891 -- Restoring the America Invents Act -- a bill to amend Title 35 USC to address matters related to the Patent Trial and Appeals Board -- overall S. 2774 -- Pride in Patent Ownership Act -- overall S. 2773 -- Unleashing American Innovation Act -- overall H.R. 5874 -- Restoring American Leadership in Innovaction Act -- overall S. 4417 -- Patent Trial and Appeals Board Reform Act -- overall S. 4543 -- National Defense Authorization Act -- regarding potential amendments related to patents S. 4734 -- Patent Eligibility Restoration Act -- overall S. 4430 -- Interagency Patent Coordination and Improvement Act -- overall S. 4704 -- Patent Examination and Quality Improvement Act -- overall Discussions on issue of march-in rights, PTAB reform overall, need for Section 101 reform
Client expense: Not reported · Firm income: $9,000
Government targets: HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE
2022 · fourth_quarter · Copyright/Patent/Trademark
S 2891, Restoring America Invents Act Issues impacting foreign infringement on US patents
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Copyright/Patent/Trademark
STRONGER Patents Act National Institute of Standards and Technology (NIST) proposed revisions to Rights to Inventions Made by Nonprofit Organizations and Small Business Firms under Government Grants, Contracts, and Cooperative Agreements and Licensing of Government-Owned Inventions (NIST Docket No. 201207-0327) Federal position on proposal at World Trade Organization to waive intellectual property protections due under Trade-Related Aspects of Intellectual Property Rights Agreement with regard to COVID-19-related inventions H.R. 3035/S. 1683 (Preventing Foreign Attempts to Erode Healthcare Innovation Act) S. 1260 (Endless Frontier Act/United States Innovation and Competition Act) patent and intellectual property-related provisions and amendments H.R. 4521 (America COMPETES Act) H.R. 4792 (Countering Communist China Act) patent and intellectual property-related provisions H.R. 1934 (Promoting United States International Leadership in 5G Act) standards development for standards-essential patents and innovation Request for Information Regarding Patent Eligibility Jurisprudence Study (Docket No. PTO-P-2021-0032) Bayh-Dole Act march-in misuse demands, including opposition to KEI petition to Health & Human Services to march in on Astellas patents on Xtandi Bayh-Dole Act exceptions to statutory licensing provisions, unilaterally imposed by Energy Dept. requiring DOE review of all licensing agreements grantees negotiate in technology transfers Patent & Trademark Office/PTAB discretion to institute or to deny trials before the Patent Trial and Appeal Board, pursuant to America Invents Act discretion; PTAB designation of precedential opinions, including the Fintiv doctrine to avoid duplicative litigation on the same patent claims in multiple forums S. 2891 (Restoring the America Invents Act) S. 2774 (Pride in Patent Ownership Act) H.R. 5874 (Restoring Americas Leadership in Innovation Act) Patent Trial and Appeal Board amicus re OpenSky Industries LLC v. VLSI Technology LLC (Case No. IPR2021-01064) Draft Policy Statement on Licensing Negotiations and Remedies for Standards-Essential Patents Subject to Voluntary F/RAND Commitments (Docket No. ATR-2021-0001) Patent eligibility/Section 101 Access to injunctive relief against patent infringers Patent Trial and Appeal Board amicus re Palo Alto Networks Inc. v. Centripetal Networks Inc. (Case No. IPR2022-00182) Patent Trial and Appeal Board amicus re OpenSky Industries LLC and Intel Corp.v. VLSI Technology LLC (Case No. IPR2021-01064) and Patent Quality Assurance LLC and Intel Corp. v. VLSI Technology LLC (Case No. IPR2021-01229) S. 3772 (Defending American Courts Act) S. 4417 (PTAB Reform Act) S. 4430 (Interagency Patent Coordination and Improvement Act) S. 4704 (Patent Examination and Quality Improvement Act) S. 4734 (Patent Eligibility Restoration Act) Request for Comments Regarding the Patent Subject Matter Eligibility Guidance (Docket No. PTO-P-2022-0026) Patent Trial and Appeal Board amicus re Samsung Electronics Co. v. Netlist, Inc. (Case No. IPR2022-00615) H.R. 2617 (legislative vehicle for the Consolidated Appropriations Act FY 2023 with Senate amendment #6552) potential patent-related policy riders
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Patent & Trademark Office (PTO), SENATE